In vitro antioxidant properties of dantrolene sodium

被引:179
|
作者
Büyükokuroglu, ME [1 ]
Gülçin, I
Oktay, M
Küfrevioglu, Ö
机构
[1] Ataturk Univ, Dept Pharmacol, Fac Med, TR-25240 Erzurum, Turkey
[2] Ataturk Univ, Dept Chem, Sci & Arts Fac, TR-25240 Erzurum, Turkey
[3] Ataturk Univ, Dept Chem, Kazim Karabekir Educ Fac, TR-25240 Erzurum, Turkey
关键词
dantrolene sodium; antioxidant; in vitro;
D O I
10.1006/phrs.2001.0890
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dantrolene sodium is a skeletal muscle relaxant, which inhibits intracellular Ca2+ release from the sarcoplasmic reticulum. The aim of this study is to examine possible in vitro antioxidant effects of dantrolene sodium. For this reason, the in vitro antioxidant effects of dantrolene sodium were studied using thiocyanate methods. Additionally, the reducing power and free radical scavenging activity were determined. Dantrolene sodium showed strong antioxidant activity in the linoleic acid emulsion system. The antioxidant activity increased with an increasing amount of dantrolene sodium (50, 100, 250 mug). The 50, 100 and 250 mug samples of dantrolene sodium showed 55%, 70% and 82% inhibition on peroxidation of linoleic acid, respectively. On the other hand, the 250 mug sample of alpha -tocopherol showed 62% inhibition of peroxidation of linoleic acid. Like antioxidant activity, the reducing power of dantrolene sodium increased in a dose-dependent manner. The reducing power of dantrolene was statistically significant vs control, but lower than butylated hydroxytoluene (BHT) and quercetin. Although dantrolene sodium had free radical scavenging activity this was not statistically significant. In contrast to dantrolene sodium, quercetin and butylated hydroxyanisole (BHA) had highly potent free radical scavenging activities and those were statistically significant. According to the these results, it may be said that antioxidant effect of dantrolene sodium is more related to its antioxidant activity in linoleic acid emulsion and reducing power, than to its free radical scavenging activity. These properties may be major reasons for the inhibition of lipid peroxidation. (C) 2001 Academic Press.
引用
收藏
页码:491 / 494
页数:4
相关论文
共 50 条
  • [21] EVALUATION OF SPASMOLYTIC PROPERTIES OF DANTROLENE SODIUM BY DOUBLE-BLIND STUDY
    SHEPLAN, L
    ISHMAEL, CW
    NEUROLOGY, 1973, 23 (04) : 397 - &
  • [22] DANTROLENE SODIUM - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN SPASTICITY
    PINDER, RM
    BROGDEN, RN
    SPEIGHT, TM
    AVERY, GS
    DRUGS, 1977, 13 (01) : 3 - 23
  • [23] DANTROLENE SODIUM FOR TREATMENT OF SPASTICITY
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1974, 16 (15): : 61 - 62
  • [24] TREATMENT OF SPASTICITY WITH DANTROLENE SODIUM
    MAYER, N
    MECOMBER, SA
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 1973, 52 (01) : 18 - 29
  • [25] DANTROLENE SODIUM AND DYSTROPHIA MYOTONICA
    PHILLIPS, DC
    ELLIS, FR
    EXLEY, KA
    NESS, MA
    ANAESTHESIA, 1984, 39 (06) : 568 - 573
  • [26] DANTROLENE SODIUM IN CHILDREN WITH SPASTICITY
    HASLAM, RHA
    WALCHER, JR
    LIETMAN, PS
    KALLMAN, CH
    MELLITS, ED
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1974, 55 (08): : 384 - 388
  • [27] PHARMACOKINETICS OF DANTROLENE SODIUM IN HORSES
    COURT, MH
    ENGELKING, LR
    DODMAN, NH
    ANWER, MS
    SEELER, DC
    CLARK, M
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1987, 10 (03) : 218 - 226
  • [28] HEPATITIS FROM DANTROLENE SODIUM
    WILKINSON, SP
    PORTMANN, B
    WILLIAMS, R
    GUT, 1979, 20 (01) : 33 - 36
  • [29] DANTROLENE SODIUM INTRAVENOUS - VERAPAMIL
    BEZER, G
    ANAESTHESIA AND INTENSIVE CARE, 1985, 13 (01) : 108 - 108
  • [30] HEPATOTOXICOLOGICAL EVALUATION OF DANTROLENE SODIUM
    DURHAM, JA
    GANDOLFI, AJ
    BENTLEY, JB
    DRUG AND CHEMICAL TOXICOLOGY, 1984, 7 (01) : 23 - 40